Matthew McBrady Biography and Net Worth

Director of Axon Enterprise

From August 1998 through January 2000, Dr. McBrady served as an international economist with President Clinton’s Council of Economic Advisers and the U.S. Treasury Department. Dr. McBrady subsequently served as a professor of finance at the Wharton School of Business at the University of Pennsylvania (from September 2002 through May 2003) and at the Darden Graduate School of Business Administration at the University of Virginia (from May 2003 through December 2006). Dr. McBrady then worked as an investment professional within the North American Private Equity group at Bain Capital, LLC (from January 2007 through January 2009). Dr. McBrady then joined Silver Creek Capital Management, LLC as Managing Director and Head of Investment Strategy and Risk Management (from January 2009 through January 2014) prior to joining BlackRock, Inc. where he served as Managing Director and Chief Investment Officer of Multi-Strategy Hedge Funds from January 2014 through September 2016. Dr. McBrady holds a B.A. degree in Economics from Harvard University, a M.S. degree in International Economics from Oxford University (U.K.), and a Masters and Ph.D. degree in Business Economics from Harvard University. Dr. McBrady previously served as a director for the Company from January 2001 through June 2014.

What is Matthew R. McBrady's net worth?: The estimated net worth of Matthew R. McBrady is at least $3.09 million as of August 9th, 2024. Dr. McBrady owns 4,892 shares of Axon Enterprise stock worth more than $3,090,227 as of December 20th. This net worth evaluation does not reflect any other assets that Dr. McBrady may own. Learn More about Matthew R. McBrady's net worth.
How do I contact Matthew R. McBrady?: The corporate mailing address for Dr. McBrady and other Axon Enterprise executives is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. Axon Enterprise can also be reached via phone at (480) 991-0797 and via email at [email protected]. Learn More on Matthew R. McBrady's contact information.
Has Matthew R. McBrady been buying or selling shares of Axon Enterprise?: Matthew R. McBrady has not been actively trading shares of Axon Enterprise during the last ninety days. Most recently, Matthew R. Mcbrady sold 2,000 shares of the business's stock in a transaction on Friday, August 9th. The shares were sold at an average price of $364.66, for a transaction totalling $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares of the company's stock, valued at $1,783,916.72. Learn More on Matthew R. McBrady's trading history.
Who are Axon Enterprise's active insiders?: Axon Enterprise's insider roster includes Jawad Ahsan (CFO), Brittany Bagley (CFO), Adriane Brown (Director), Julie Cullivan (Director), Michael Garnreiter (Director), Joshua Isner (CRO), Caitlin Kalinowski (Director), Mark Kroll (Director), Jeffrey Kunins (Insider), Luke Larson (President), Matthew McBrady (Director), Hadi Partovi (Director), Patrick Smith (Co-Founder, CEO & Director), and Jeri Williams (Director). Learn More on Axon Enterprise's active insiders.
Are insiders buying or selling shares of Axon Enterprise?: In the last year, insiders at the biotechnology company sold shares 28 times. They sold a total of 545,079 shares worth more than $203,397,488.95. The most recent insider tranaction occured on December, 17th when President Joshua Isner sold 1,291 shares worth more than $829,377.13. Insiders at Axon Enterprise own 6.1% of the company. Learn More about insider trades at Axon Enterprise.
Information on this page was last updated on 12/17/2024.

Matthew R. McBrady Insider Trading History at Axon Enterprise

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2024	Sell	2,000	$364.66	$729,320.00	4,892
11/11/2022	Sell	1,699	$182.88	$310,713.12	5,651
6/16/2021	Sell	660	$155.47	$102,610.20	5,337
3/16/2021	Sell	911	$147.38	$134,263.18	4,563
3/12/2021	Sell	1,060	$152.63	$161,787.80

Matthew R. McBrady Buying and Selling Activity at Axon Enterprise

Axon Enterprise Company Overview

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include axon officer safety plan; taser 10, taser7, taser X26P, taser X2, taser 7 CQ, and civilian series; cameras, such as axon body, axon flex, axon fleet, axon air, axon signal sidearm, axon signal vehicle, axon interview, and axon interview portable kit; software, including axon records, evidence, standards, commander, performance, auto-transcribe, justice, investigate, respond, and justice, my90, and redaction assistant; mobile applications, and training services, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. The company sells its products through its direct sales, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand bility to aggregate live video, data, and sensor feeds. It serves law enforcement, federal, correction, fire, EMS, campus, justice healthcare, retail, private security, and personal safety industries. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Today's Range

Now: $631.69

$605.09

$633.21

50 Day Range

MA: $555.56

$423.50

$689.78

2 Week Range

Now: $631.69

$241.72

$698.67

Volume

7,025,547 shs

Average Volume

614,709 shs

Market Capitalization

$48.17 billion

P/E Ratio

163.23

Dividend Yield

N/A

Beta

1.01

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.